A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management with LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants with Obesity or Overweight with T2D
A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management with LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants with Obesity or Overweight with T2D